Soreide Law Group is investigating potential investor claims of sales practice violations possibly committed by securities broker Thomas Joseph Livaccari [CRD: 2376606, New York, New York], according to disclosures on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Evidently, Thomas Livaccari joined UBS Financial Services Inc. on January 22, 2009. Here’s more about the securities broker’s disclosures.
UBS Financial Services Inc. Investor Accused Livaccari Of Misrepresentation
Specifically, a client filed a complaint about Thomas Livaccari. The client alleged that Livaccari made misrepresentations. Because of this, the client allegedly sustained damages on hedge funds. Therefore, on April 25, 2023, UBS Financial Services Inc. settled this matter by paying the client $75,000 in damages.
Investor Accused Thomas Livaccari Of Unsuitability
Particularly, on October 22, 2019, a UBS Financial Services Inc. client filed a complaint about Livaccari. Supposedly, Livaccari made misrepresentations and unsuitable recommendations with respect to options overlay strategies. Because of this, the client allegedly sustained damages. As a result, the client requested $500,000 in compensation from UBS Financial Services Inc. or Livaccari. This complaint closed without a resolution.
Livaccari Disclosed Unsuitable Recommendation Allegations By Merrill Lynch Client
Also, a client of Merrill Lynch contested Thomas Livaccari’s sales practices, according to a complaint dated December 16, 2008. Allegedly, Livaccari made unsuitable recommendations of mutual funds. Therefore, the client sought compensation from Merrill Lynch or Livaccari in the amount of $84,000 in this matter. The firm denied this complaint.
Did You Sustain Losses Because Of Securities Broker Thomas Livaccari?
Suffered losses because of Thomas Livaccari? If you have, reach out to Soreide Law Group online or at (888) 760-6552 and talk with a securities attorney about your legal options. Soreide Law Group has recovered losses for many clients in the US, represents investors through contingency fees, and advances all costs. Livaccari and brokerage firms Livaccari worked for deny any allegations of sales practice violations.